what to avoid when taking semaglutide Food List and Feeling thirstier than usual on

Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide

Thats when we started rationing our stocks, as well as what we dispense to each patient). With a monthly allocation limit of two Ozempic pens per dosage, accessing the drug has become strenuous for consumers

For the science behind Retatrutide, see What Is Retatrutide

doi:10.26502/aimr.0189

Currently, the only dual GLP-1/GIP receptor agonist available is Mounjaro

Thats where NOW CFO comes in